User profiles for Takeshi Saraya

TAKESHI SARAYA

Kyorin University School of Medicine
Verified email at yd5.so-net.ne.jp
Cited by 3374

The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features

…, I Katzan, CJ Gardner, M Hausler, R Nau, T Saraya… - Neurology, 2008 - AAN Enterprises
Background: Varicella zoster virus (VZV) vasculopathy produces stroke secondary to viral
infection of cerebral arteries. Not all patients have rash before cerebral ischemia or stroke. …

[HTML][HTML] Virus-induced exacerbations in asthma and COPD

D Kurai, T Saraya, H Ishii, H Takizawa - Frontiers in microbiology, 2013 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation
and/or airflow limitation due to pulmonary emphysema. Chronic bronchitis, pulmonary …

[HTML][HTML] Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications

T Saraya, D Kurai, K Nakagaki, Y Sasaki… - Frontiers in …, 2014 - frontiersin.org
Mycoplasma pneumoniae (Mp) is a leading cause of community acquired pneumonia.
Knowledge regarding Mp pneumonia obtained from animal models or human subjects has been …

Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis/dermatomyositis–associated interstitial lung disease

…, Y Wada, K Ishii, S Fujiwara, T Saraya… - Arthritis & …, 2021 - Wiley Online Library
Objective To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated
interstitial lung disease (PM/DM‐ILD) using a combination of initial serum …

[HTML][HTML] Efficacy and safety of favipiravir in moderate COVID-19 pneumonia patients without oxygen therapy: a randomized, phase III clinical trial

…, Y Hirai, S Fujiwara, Y Komase, T Saraya… - Infectious diseases and …, 2021 - Springer
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of
coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded RNA virus. …

[HTML][HTML] Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

…, H Elinav, A Michael-Gayego, T Oishi, T Saraya… - The Lancet …, 2024 - thelancet.com
Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired
pneumonia as the major disease-related burden. Compared with other pathogens, …

IL-17A synergistically stimulates TNF-α-induced IL-8 production in human airway epithelial cells: a potential role in amplifying airway inflammation

…, T Koide, S Takata, T Yokoyama, T Saraya… - Experimental lung …, 2016 - Taylor & Francis
Background: Recent reports have suggested an involvement of neutrophilic inflammation
driven by interleukin (IL)-17 from Th17 cells, especially in severe, refractory asthma. It remains …

[HTML][HTML] Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan

…, N Uchida, A Nishida, Y Kogure, T Saraya… - BMC pulmonary …, 2014 - Springer
Background Secondary pulmonary alveolar proteinosis (sPAP) is a very rare lung disorder
comprising approximately 10% of cases of acquired PAP. Hematological disorders are the …

[HTML][HTML] Epidemiology of virus-induced asthma exacerbations: with special reference to the role of human rhinovirus

T Saraya, D Kurai, H Ishii, A Ito, Y Sasaki… - Frontiers in …, 2014 - frontiersin.org
Viral respiratory infections may be associated with the virus-induced asthma in adults as well
as children. Particularly, human rhinovirus is strongly suggested a major candidate for the …

Mycoplasma pneumoniae infection: Basics

T Saraya - Journal of General and Family Medicine, 2017 - Wiley Online Library
Mycoplasma pneumoniae (Mp) is one of the leading causes of community‐acquired pneumonia
and can cause a number of extrapulmonary manifestations in the absence of pneumonia…